TP53 and cancer: Measurements of cell viability (Fig. 2f), apoptosis (Fig. 2g), and colony growth (Fig. 2h) concurred with the suggestion that loss of p53 either through non-sense or missense mutation predisposes cancer cells to niclosamide.